Animal models for studying dengue pathogenesis and therapy

Antiviral Research

Volumn 123, Issue , 2015, Pages 5-14

  Chan, Kitti Wing Ki ^a,b   Watanabe, Satoru ^a   Kavishna, Ranmali ^b,c   Alonso, Sylvie ^b,c   Vasudevan, Subhash G ^a,b  

^a DUKE NUS MEDICAL SCHOOL   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

AG129 mice; Animal models; Antiviral therapy; Dengue; Dengue hemorrhagic fever

Indexed keywords

ANTIBODY; ANTIVIRUS AGENT; DENGUE VACCINE;

ANIMAL MODEL; ANTIBODY DEPENDENT ENHANCEMENT; ANTIGEN ANTIBODY COMPLEX; ANTIVIRAL THERAPY; DENGUE; EXPERIMENTAL MOUSE; HUMANIZED MICE; IMMUNOCOMPETENT MICE; IMMUNOCOMPROMISED MICE; MOUSE MODEL; NONHUMAN; PRIMATE; PRIORITY JOURNAL; REVIEW; SUCKLING MICE; VIRUS PATHOGENESIS; ANIMAL; DENGUE VIRUS; DISEASE MODEL; PATHOGENICITY; PRECLINICAL STUDY; PROCEDURES; VIROLOGY;

ANIMALIA; DENGUE VIRUS; FLAVIVIRUS; MUS;

ANIMALS; DENGUE; DENGUE VIRUS; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL;

EID: 84940396925     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2015.08.013     Document Type: Review

References (102)

1. J. An, J. Kimura-Kuroda, Y. Hirabayashi, and K. Yasui Development of a novel mouse model for dengue virus infection Virology 263 1999 70 77
2. S.J. Balsitis, K.L. Williams, R. Lachica, D. Flores, J.L. Kyle, E. Mehlhop, S. Johnson, M.S. Diamond, P.R. Beatty, and E. Harris Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification PLoS Pathog. 6 2010 e1000790
3. D.A. Bente, M.W. Melkus, J.V. Garcia, and R. Rico-Hesse Dengue fever in humanized NOD/SCID mice J. Virol. 79 2005 13797 13799
4. S. Bhatt, P.W. Gething, O.J. Brady, J.P. Messina, A.W. Farlow, C.L. Moyes, J.M. Drake, J.S. Brownstein, A.G. Hoen, O. Sankoh, M.F. Myers, D.B. George, T. Jaenisch, G.R. Wint, C.P. Simmons, T.W. Scott, J.J. Farrar, and S.I. Hay The global distribution and burden of dengue Nature 2013 504 507
5. J.E. Blaney Jr., J.M. Matro, B.R. Murphy, and S.S. Whitehead Recombinant, live-attenuated tetravalent dengue virus vaccine formulations induce a balanced, broad, and protective neutralizing antibody response against each of the four serotypes in rhesus monkeys J. Virol. 79 2005 5516 5528
6. J.R. Bravo, M.G. Guzman, and G.P. Kouri Why dengue haemorrhagic fever in Cuba? 1. Individual risk factors for dengue haemorrhagic fever/dengue shock syndrome (DHF/DSS) Trans. R. Soc. Trop. Med. Hyg. 81 1987 816 820
7. M.R. Capeding, N.H. Tran, S.R. Hadinegoro, H.I. Ismail, T. Chotpitayasunondh, M.N. Chua, C.Q. Luong, K. Rusmil, D.N. Wirawan, R. Nallusamy, P. Pitisuttithum, U. Thisyakorn, I.K. Yoon, D. van der Vliet, E. Langevin, T. Laot, Y. Hutagalung, C. Frago, M. Boaz, T.A. Wartel, N.G. Tornieporth, M. Saville, A. Bouckenooghe Group, C.Y.D.S. Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial Lancet 384 2014 1358 1365
8. J. Chang, W. Schul, T.D. Butters, A. Yip, B. Liu, A. Goh, S.B. Lakshminarayana, D. Alonzi, G. Reinkensmeier, X. Pan, X. Qu, J.M. Weidner, L. Wang, W. Yu, N. Borune, M.A. Kinch, J.E. Rayahin, R. Moriarty, X. Xu, P.Y. Shi, J.T. Guo, and T.M. Block Combination of alpha-glucosidase inhibitor and ribavirin for the treatment of dengue virus infection in vitro and in vivo Antiviral Res. 89 2011 26 34
9. T.N. Chau, N.T. Hieu, K.L. Anders, M. Wolbers, B. Lien le, L.T. Hieu, T.T. Hien, N.T. Hung, J. Farrar, S. Whitehead, and C.P. Simmons Dengue virus infections and maternal antibody decay in a prospective birth cohort study of Vietnamese infants J. Infect. Dis. 200 2009 1893 1900
10. T.N. Chau, N.T. Quyen, T.T. Thuy, N.M. Tuan, D.M. Hoang, N.T. Dung, B. Lien le, N.T. Quy, N.T. Hieu, L.T. Hieu, T.T. Hien, N.T. Hung, J. Farrar, and C.P. Simmons Dengue in Vietnamese infants-results of infection-enhancement assays correlate with age-related disease epidemiology, and cellular immune responses correlate with disease severity J. Infect. Dis. 198 2008 516 524
11. H.C. Chen, F.M. Hofman, J.T. Kung, Y.D. Lin, and B.A. Wu-Hsieh Both virus and tumor necrosis factor alpha are critical for endothelium damage in a mouse model of dengue virus-induced hemorrhage J. Virol. 81 2007 5518 5526
12. H.C. Chen, S.Y. Lai, J.M. Sung, S.H. Lee, Y.C. Lin, W.K. Wang, Y.C. Chen, C.L. Kao, C.C. King, and B.A. Wu-Hsieh Lymphocyte activation and hepatic cellular infiltration in immunocompetent mice infected by dengue virus J. Med. Virol. 73 2004 419 431
13. S.T. Chen, Y.L. Lin, M.T. Huang, M.F. Wu, S.C. Cheng, H.Y. Lei, C.K. Lee, T.W. Chiou, C.H. Wong, and S.L. Hsieh CLEC5A is critical for dengue-virus-induced lethal disease Nature 453 2008 672 676
14. T. Dong, E. Moran, N. Vinh Chau, C. Simmons, K. Luhn, Y. Peng, B. Wills, N. Phuong Dung, L. Thi Thu Thao, T.T. Hien, A. McMichael, J. Farrar, and S. Rowland-Jones High pro-inflammatory cytokine secretion and loss of high avidity cross-reactive cytotoxic T-cells during the course of secondary dengue virus infection PLoS ONE 2 2007 e1192
15. T. Duangchinda, W. Dejnirattisai, S. Vasanawathana, W. Limpitikul, N. Tangthawornchaikul, P. Malasit, J. Mongkolsapaya, and G. Screaton Immunodominant T-cell responses to dengue virus NS3 are associated with DHF Proc. Natl. Acad. Sci. U.S.A. 107 2010 16922 16927
16. A.P. Durbin, and S.S. Whitehead The dengue human challenge model: has the time come to accept this challenge? J. Infect. Dis. 207 2013 697 699
17. J.E. Fraser, S. Watanabe, C. Wang, W.K. Chan, B. Maher, A. Lopez-Denman, C. Hick, K.M. Wagstaff, J.M. Mackenzie, P.M. Sexton, S.G. Vasudevan, and D.A. Jans A nuclear transport inhibitor that modulates the unfolded protein response and provides in vivo protection against lethal dengue virus infection J. Infect. Dis. 210 2014 1780 1791
18. N. Frias-Staheli, M. Dorner, S. Marukian, E. Billerbeck, R.N. Labitt, C.M. Rice, and A. Ploss Utility of humanized BLT mice for analysis of dengue virus infection and antiviral drug testing J. Virol. 88 2014 2205 2218
19. L. Gil, A. Izquierdo, L. Lazo, I. Valdes, P. Ambala, L. Ochola, E. Marcos, E. Suzarte, T. Kariuki, G. Guzman, G. Guillen, and L. Hermida Capsid protein: evidences about the partial protective role of neutralizing antibody-independent immunity against dengue in monkeys Virology 456-457 2014 70 76
20. A.P. Goncalvez, R.E. Engle, M. St Claire, R.H. Purcell, and C.J. Lai Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention Proc. Natl. Acad. Sci. U.S.A. 104 2007 9422 9427
21. A.M. Green, P.R. Beatty, A. Hadjilaou, and E. Harris Innate immunity to dengue virus infection and subversion of antiviral responses J. Mol. Biol. 426 2014 1148 1160
22. D.J. Gubler Dengue/dengue haemorrhagic fever: history and current status Novartis Found. Symp. 277 2006 3 16 discussion 16-22, 71-13, 251-253
23. F. Guirakhoo, K. Pugachev, Z. Zhang, G. Myers, I. Levenbook, K. Draper, J. Lang, S. Ocran, F. Mitchell, M. Parsons, N. Brown, S. Brandler, C. Fournier, B. Barrere, F. Rizvi, A. Travassos, R. Nichols, D. Trent, and T. Monath Safety and efficacy of chimeric yellow fever-dengue virus tetravalent vaccine formulations in nonhuman primates J. Virol. 78 2004 4761 4775
24. V.J. Gunther, R. Putnak, K.H. Eckels, M.P. Mammen, J.M. Scherer, A. Lyons, M.B. Sztein, and W. Sun A human challenge model for dengue infection reveals a possible protective role for sustained interferon gamma levels during the acute phase of illness Vaccine 29 2011 3895 3904
25. B. Guy, V. Barban, N. Mantel, M. Aguirre, S. Gulia, J. Pontvianne, T.-M. Jourdier, L. Ramirez, V. Gregoire, C. Charnay, N. Burdin, R. Dumas, and J. Lang Evaluation of interferences between dengue vaccine serotypes in a monkey model Am. J. Trop. Med. Hyg. 80 2009 302 311
26. M.G. Guzman, M. Alvarez, and S.B. Halstead Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection Arch. Virol. 158 2013 1445 1459
27. M.G. Guzman, and E. Harris Dengue Lancet 385 9966 2015 453 465
28. S.B. Halstead In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody J. Infect. Dis. 140 1979 527 533
29. S.B. Halstead The Alexander D. Langmuir Lecture. The pathogenesis of dengue. Molecular epidemiology in infectious disease Am. J. Epidemiol. 114 1981 632 648
30. S.B. Halstead Pathogenesis of dengue: challenges to molecular biology Science 239 1988 476 481
31. S.B. Halstead Neutralization and antibody-dependent enhancement of dengue viruses Adv. Virus Res. 60 2003 421 467
32. S.B. Halstead Dengue Lancet 370 2007 1644 1652
33. S.B. Halstead, N.T. Lan, T.T. Myint, T.N. Shwe, A. Nisalak, S. Kalyanarooj, S. Nimmannitya, S. Soegijanto, D.W. Vaughn, and T.P. Endy Dengue hemorrhagic fever in infants: research opportunities ignored Emerg. Infect. Dis. 8 2002 1474 1479
34. S.B. Halstead, H. Shotwell, and J. Casals Studies on the pathogenesis of dengue infection in monkeys. I. Clinical laboratory responses to primary infection J. Infect. Dis. 128 1973 7 14
35. S.B. Halstead, H. Shotwell, and J. Casals Studies on the pathogenesis of dengue infection in monkeys. II. Clinical laboratory responses to heterologous infection J. Infect. Dis. 128 1973 15 22
36. K.J. Huang, S.Y. Li, S.C. Chen, H.S. Liu, Y.S. Lin, T.M. Yeh, C.C. Liu, and H.Y. Lei Manifestation of thrombocytopenia in dengue-2-virus-infected mice J. Gen. Virol. 81 2000 2177 2182
37. A.J. Johnson, and J.T. Roehrig New mouse model for dengue virus vaccine testing J. Virol. 73 1999 783 786
38. N. Kanesa-thasan, W. Sun, G. Kim-Ahn, S. Van Albert, J.R. Putnak, A. King, B. Raengsakulsrach, H. Christ-Schmidt, K. Gilson, J.M. Zahradnik, D.W. Vaughn, B.L. Innis, J.F. Saluzzo, and C.H. Hoke Jr. Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers Vaccine 19 2001 3179 3188
39. S.C. Kliks, S. Nimmanitya, A. Nisalak, and D.S. Burke Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants Am. J. Trop. Med. Hyg. 38 1988 411 419
40. J.G. Kuruvilla, R.M. Troyer, S. Devi, and R. Akkina Dengue virus infection and immune response in humanized RAG2(-/-)gamma(c)(-/-) (RAG-hu) mice Virology 369 2007 143 152
41. J.L. Kyle, S.J. Balsitis, L. Zhang, P.R. Beatty, and E. Harris Antibodies play a greater role than immune cells in heterologous protection against secondary dengue virus infection in a mouse model Virology 380 2008 296 303
42. J.C. Lee, C.K. Tseng, Y.H. Wu, N. Kaushik-Basu, C.K. Lin, W.C. Chen, and H.N. Wu Characterization of the activity of 2′-C-methylcytidine against dengue virus replication Antiviral Res. 116C 2015 1 9
43. Y.R. Lee, H.Y. Hu, S.H. Kuo, H.Y. Lei, Y.S. Lin, T.M. Yeh, C.C. Liu, and H.S. Liu Dengue virus infection induces autophagy: an in vivo study J. Biomed. Sci. 20 2013 65
44. Y.R. Lee, K.J. Huang, H.Y. Lei, S.H. Chen, Y.S. Lin, T.M. Yeh, and H.S. Liu Suckling mice were used to detect infectious dengue-2 viruses by intracerebral injection of the full-length RNA transcript Intervirology 48 2005 161 166
45. D.H. Libraty, L.P. Acosta, V. Tallo, E. Segubre-Mercado, A. Bautista, J.A. Potts, R.G. Jarman, I.K. Yoon, R.V. Gibbons, J.D. Brion, and R.Z. Capeding A prospective nested case-control study of Dengue in infants: rethinking and refining the antibody-dependent enhancement dengue hemorrhagic fever model PLoS Med. 6 2009 e1000171
46. Y.L. Lin, C.L. Liao, L.K. Chen, C.T. Yeh, C.I. Liu, S.H. Ma, Y.Y. Huang, Y.L. Huang, C.L. Kao, and C.C. King Study of Dengue virus infection in SCID mice engrafted with human K562 cells J. Virol. 72 1998 9729 9737
47. M.P. Mammen, A. Lyons, B.L. Innis, W. Sun, D. McKinney, R.C. Chung, K.H. Eckels, R. Putnak, N. Kanesa-thasan, J.M. Scherer, J. Statler, L.V. Asher, S.J. Thomas, and D.W. Vaughn Evaluation of dengue virus strains for human challenge studies Vaccine 32 2014 1488 1494
48. G.N. Milligan, V.V. Sarathy, E. Infante, L. Li, G.A. Campbell, P.R. Beatty, E. Harris, A.D. Barrett, and N. Bourne A dengue virus type 4 model of disseminated lethal infection in AG129 mice PLoS ONE 10 2015 e0125476
49. J. Mota, and R. Rico-Hesse Humanized mice show clinical signs of dengue fever according to infecting virus genotype J. Virol. 83 2009 8638 8645
50. J. Mota, and R. Rico-Hesse Dengue virus tropism in humanized mice recapitulates human dengue fever PLoS ONE 6 2011 e20762
51. J.K. Ng, S.L. Zhang, H.C. Tan, B. Yan, J.M. Martinez, W.Y. Tan, J.H. Lam, G.K. Tan, E.E. Ooi, and S. Alonso First experimental in vivo model of enhanced dengue disease severity through maternally acquired heterotypic dengue antibodies PLoS Pathog. 10 2014 e1004031
52. T. Omatsu, M.L. Moi, T. Hirayama, T. Takasaki, S. Nakamura, S. Tajima, M. Ito, T. Yoshida, A. Saito, Y. Katakai, H. Akari, and I. Kurane Common marmoset (Callithrix jacchus) as a primate model of dengue virus infection: development of high levels of viraemia and demonstration of protective immunity J. Gen. Virol. 92 2011 2272 2280
53. T. Omatsu, M.L. Moi, T. Takasaki, S. Nakamura, Y. Katakai, S. Tajima, M. Ito, T. Yoshida, A. Saito, H. Akari, and I. Kurane Changes in hematological and serum biochemical parameters in common marmosets (Callithrix jacchus) after inoculation with dengue virus J. Med. Primatol. 41 2012 289 296
54. N. Onlamoon, S. Noisakran, H.M. Hsiao, A. Duncan, F. Villinger, A.A. Ansari, and G.C. Perng Dengue virus-induced hemorrhage in a nonhuman primate model Blood 115 2010 1823 1834
55. S. Orozco, M.A. Schmid, P. Parameswaran, R. Lachica, M.R. Henn, R. Beatty, and E. Harris Characterization of a model of lethal dengue virus 2 infection in C57BL/6 mice deficient in the alpha/beta interferon receptor J. Gen. Virol. 93 2012 2152 2157
56. J.E. Osorio, J.N. Brewoo, S.J. Silengo, J. Arguello, I.R. Moldovan, M. Tary-Lehmann, T.D. Powell, J.A. Livengood, R.M. Kinney, C.Y. Huang, and D.T. Stinchcomb Efficacy of a tetravalent chimeric dengue vaccine (DENVax) in Cynomolgus macaques Am. J. Trop. Med. Hyg. 84 2011 978 987
57. J.S. Oxford Towards a universal influenza vaccine: volunteer virus challenge studies in quarantine to speed the development and subsequent licensing Br. J. Clin. Pharmacol. 76 2013 210 216
58. A.K. Palucka, J. Gatlin, J.P. Blanck, M.W. Melkus, S. Clayton, H. Ueno, E.T. Kraus, P. Cravens, L. Bennett, A. Padgett-Thomas, F. Marches, M. Islas-Ohlmayer, J.V. Garcia, and J. Banchereau Human dendritic cell subsets in NOD/SCID mice engrafted with CD34+ hematopoietic progenitors Blood 102 2003 3302 3310
59. S.T. Perry, M.D. Buck, S.M. Lada, C. Schindler, and S. Shresta STAT2 mediates innate immunity to Dengue virus in the absence of STAT1 via the type I interferon receptor PLoS Pathog. 7 2011 e1001297
60. S.T. Perry, M.D. Buck, E.M. Plummer, R.A. Penmasta, H. Batra, E.J. Stavale, K.L. Warfield, R.A. Dwek, T.D. Butters, D.S. Alonzi, S.M. Lada, K. King, B. Klose, U. Ramstedt, and S. Shresta An iminosugar with potent inhibition of dengue virus infection in vivo Antiviral Res. 98 2013 35 43
61. T.R. Prestwood, M.M. Morar, R.M. Zellweger, R. Miller, M.M. May, L.E. Yauch, S.M. Lada, and S. Shresta Gamma interferon (IFN-gamma) receptor restricts systemic dengue virus replication and prevents paralysis in IFN-alpha/beta receptor-deficient mice J. Virol. 86 2012 12561 12570
62. T.R. Prestwood, D.M. Prigozhin, K.L. Sharar, R.M. Zellweger, and S. Shresta A mouse-passaged dengue virus strain with reduced affinity for heparan sulfate causes severe disease in mice by establishing increased systemic viral loads J. Virol. 82 2008 8411 8421
63. A.P.S. Rathore, P.N. Paradkar, S. Watanabe, K.H. Tan, C. Sung, J.E. Connolly, J. Low, E.E. Ooi, and S.G. Vasudevan Celgosivir treatment misfolds dengue virus NS1 protein, induces cellular pro-survival genes and protects against lethal challenge mouse model Antiviral Res. 92 2011 453 460
64. A. Sabchareon, D. Wallace, C. Sirivichayakul, K. Limkittikul, P. Chanthavanich, S. Suvannadabba, V. Jiwariyavej, W. Dulyachai, K. Pengsaa, T.A. Wartel, A. Moureau, M. Saville, A. Bouckenooghe, S. Viviani, N.G. Tornieporth, and J. Lang Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial Lancet 380 2012 1559 1567
65. A.B. Sabin, and R.W. Schlesinger Production of immunity to dengue with virus modified by propagation in mice Science 101 1945 640 642
66. V.V. Sarathy, M. White, L. Li, S.R. Gorder, R.B. Pyles, G.A. Campbell, G.N. Milligan, N. Bourne, and A.D. Barrett A lethal murine infection model for dengue virus 3 in AG129 mice deficient in type I and II interferon receptors leads to systemic disease J. Virol. 89 2015 1254 1266
67. W.F. Scherer, P.K. Russell, L. Rosen, J. Casals, and R.W. Dickerman Experimental infection of chimpanzees with dengue viruses Am. J. Trop. Med. Hyg. 27 1978 590 599
68. W. Schul, W. Liu, H.Y. Xu, M. Flamand, and S.G. Vasudevan A dengue fever viremia model in mice shows reduction in viral replication and suppression of the inflammatory response after treatment with antiviral drugs J. Infect. Dis. 195 2007 665 674
69. S. Shresta, J.L. Kyle, P. Robert Beatty, and E. Harris Early activation of natural killer and B cells in response to primary dengue virus infection in A/J mice Virology 319 2004 262 273
70. S. Shresta, J.L. Kyle, H.M. Snider, M. Basavapatna, P.R. Beatty, and E. Harris Interferon-dependent immunity is essential for resistance to primary dengue virus infection in mice, whereas T- and B-cell-dependent immunity are less critical J. Virol. 78 2004 2701 2710
71. S. Shresta, K.L. Sharar, D.M. Prigozhin, P.R. Beatty, and E. Harris Murine model for dengue virus-induced lethal disease with increased vascular permeability J. Virol. 80 2006 10208 10217
72. S. Shresta, K.L. Sharar, D.M. Prigozhin, H.M. Snider, P.R. Beatty, and E. Harris Critical roles for both STAT1-dependent and STAT1-independent pathways in the control of primary dengue virus infection in mice J. Immunol. 175 2005 3946 3954
73. C.P. Simmons, T. Dong, N.V. Chau, N.T. Dung, T.N. Chau, T.T. Thao le, N.T. Dung, T.T. Hien, S. Rowland-Jones, and J. Farrar Early T-cell responses to dengue virus epitopes in Vietnamese adults with secondary dengue virus infections J. Virol. 79 2005 5665 5675
74. C.P. Simmons, S. Popper, C. Dolocek, T.N. Chau, M. Griffiths, N.T. Dung, T.H. Long, D.M. Hoang, N.V. Chau, T.T. Thao le, T.T. Hien, D.A. Relman, and J. Farrar Patterns of host genome-wide gene transcript abundance in the peripheral blood of patients with acute dengue hemorrhagic fever J. Infect. Dis. 195 2007 1097 1107
75. C.P. Simmons, J.J. Farrar, v.V. Nguyen, and B. Wills Dengue N. Engl. J. Med. 366 15 2012 1423 1432
76. M. Spring, M. Polhemus, and C. Ockenhouse Controlled human malaria infection J. Infect. Dis. 209 Suppl. 2 2014 S40 S45
77. A. Sridharan, Q. Chen, K.F. Tang, E.E. Ooi, M.L. Hibberd, and J. Chen Inhibition of megakaryocyte development in the bone marrow underlies dengue virus-induced thrombocytopenia in humanized mice J. Virol. 87 2013 11648 11658
78. St John, A.L., Rathore, A.P., Raghavan, B., Ng, M.-L., Abraham, S.N., 2013. Contributions of mast cells and vasoactive products, leukotrienes and chymase, to dengue virus-induced vascular leakage.
79. J. Statler, M. Mammen, A. Lyons, and W. Sun Sonographic findings of healthy volunteers infected with dengue virus J. Clin. Ultrasound: JCU 36 2008 413 417
80. W. Sun, K.H. Eckels, J.R. Putnak, A.G. Lyons, S.J. Thomas, D.W. Vaughn, R.V. Gibbons, S. Fernandez, V.J. Gunther, M.P. Mammen Jr., J.D. Statler, and B.L. Innis Experimental dengue virus challenge of human subjects previously vaccinated with live attenuated tetravalent dengue vaccines J. Infect. Dis. 207 2013 700 708
81. W. Sun, R. Edelman, N. Kanesa-Thasan, K.H. Eckels, J.R. Putnak, A.D. King, H.S. Houng, D. Tang, J.M. Scherer, C.H. Hoke Jr., and B.L. Innis Vaccination of human volunteers with monovalent and tetravalent live-attenuated dengue vaccine candidates Am. J. Trop. Med. Hyg. 69 2003 24 31
82. G.K. Tan, J.K. Ng, S.L. Trasti, W. Schul, G. Yip, and S. Alonso A non mouse-adapted dengue virus strain as a new model of severe dengue infection in AG129 mice PLoS Negl. Trop. Dis. 4 2010 e672
83. S.J. Thomas Dengue human infection model: re-establishing a tool for understanding dengue immunology and advancing vaccine development Hum. Vaccines Immunother. 9 2013 1587 1590
84. S.J. Thomas Developing a dengue vaccine: progress and future challenges Ann. N. Y. Acad. Sci. 1323 2014 140 159
85. E. Traggiai, L. Chicha, L. Mazzucchelli, L. Bronz, J.C. Piffaretti, A. Lanzavecchia, and M.G. Manz Development of a human adaptive immune system in cord blood cell-transplanted mice Science 304 2004 104 107
86. L. Villar, G.H. Dayan, J.L. Arredondo-Garcia, D.M. Rivera, R. Cunha, C. Deseda, H. Reynales, M.S. Costa, J.O. Morales-Ramirez, G. Carrasquilla, L.C. Rey, R. Dietze, K. Luz, E. Rivas, M.C. Miranda Montoya, M. Cortes Supelano, B. Zambrano, E. Langevin, M. Boaz, N. Tornieporth, M. Saville, F. Noriega Group, C.Y.D.S. Efficacy of a tetravalent dengue vaccine in children in Latin America N. Engl. J. Med. 372 2015 113 123
87. C.S. Waddington, T.C. Darton, W.E. Woodward, B. Angus, M.M. Levine, and A.J. Pollard Advancing the management and control of typhoid fever: a review of the historical role of human challenge studies J. Infect. 68 2014 405 418
88. S. Watanabe, K.W. Chan, J. Wang, L. Rivino, S.M. Lok, and S.G. Vasudevan Dengue virus infection with highly-neutralizing levels of cross-reactive antibodies cause acute lethal small intestinal pathology without high level of viremia in mice J. Virol. 2015
89. S. Watanabe, A.P. Rathore, C. Sung, F. Lu, Y.M. Khoo, J. Connolly, J. Low, E.E. Ooi, H.S. Lee, and S.G. Vasudevan Dose- and schedule-dependent protective efficacy of celgosivir in a lethal mouse model for dengue virus infection informs dosing regimen for a proof of concept clinical trial Antiviral Res. 96 2012 32 35
90. S. Watanabe, K.H. Tan, A.P. Rathore, K. Rozen-Gagnon, W. Shuai, C. Ruedl, and S.G. Vasudevan The magnitude of dengue virus NS1 protein secretion is strain dependent and does not correlate with severe pathologies in the mouse infection model J. Virol. 86 2012 5508 5514
91. A.K. Wege, M.W. Melkus, P.W. Denton, J.D. Estes, and J.V. Garcia Functional and phenotypic characterization of the humanized BLT mouse model Curr. Top. Microbiol. Immunol. 324 2008 149 165
92. D. Weiskopf, M.A. Angelo, E.L. de Azeredo, J. Sidney, J.A. Greenbaum, A.N. Fernando, A. Broadwater, R.V. Kolla, A.D. De Silva, A.M. de Silva, K.A. Mattia, B.J. Doranz, H.M. Grey, S. Shresta, B. Peters, and A. Sette Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells Proc. Natl. Acad. Sci. U.S.A. 110 2013 E2046 E2053
93. J. Whitehorn, V.C.N. Van, and C.P. Simmons Dengue human infection models supporting drug development J. Infect. Dis. 209 2014 S66 S70
94. A. Yamanaka, and E. Konishi A simple method for evaluating dengue vaccine effectiveness in mice based on levels of viremia caused by intraperitoneal injection of infected culture cells Vaccine 27 2009 3735 3743
95. L.E. Yauch, T.R. Prestwood, M.M. May, M.M. Morar, R.M. Zellweger, B. Peters, A. Sette, and S. Shresta CD4+ T cells are not required for the induction of dengue virus-specific CD8+ T cell or antibody responses but contribute to protection after vaccination J. Immunol. 185 2010 5405 5416
96. L.E. Yauch, R.M. Zellweger, M.F. Kotturi, A. Qutubuddin, J. Sidney, B. Peters, T.R. Prestwood, A. Sette, and S. Shresta A protective role for dengue virus-specific CD8+ T cells J. Immunol. 182 2009 4865 4873
97. Z. Yin, Y.L. Chen, W. Schul, Q.Y. Wang, F. Gu, J. Duraiswamy, R.R. Kondreddi, P. Niyomrattanakit, S.B. Lakshminarayana, A. Goh, H.Y. Xu, W. Liu, B. Liu, J.Y. Lim, C.Y. Ng, M. Qing, C.C. Lim, A. Yip, G. Wang, W.L. Chan, H.P. Tan, K. Lin, B. Zhang, G. Zou, K.A. Bernard, C. Garrett, K. Beltz, M. Dong, M. Weaver, H. He, A. Pichota, V. Dartois, T.H. Keller, and P.Y. Shi An adenosine nucleoside inhibitor of dengue virus Proc. Natl. Acad. Sci. U.S.A. 106 2009 20435 20439
98. R.M. Zellweger, T.R. Prestwood, and S. Shresta Enhanced infection of liver sinusoidal endothelial cells in a mouse model of antibody-induced severe dengue disease Cell Host Microbe 7 2010 128 139
99. R.M. Zellweger, W.W. Tang, W.E. Eddy, K. King, M.C. Sanchez, and S. Shresta CD8+ T cells can mediate short-term protection against heterotypic dengue reinfection in mice J. Virol. 2015
100. H. Zhao, T. Jiang, X.-Z. Zhou, Y.-Q. Deng, X.-F. Li, S.-P. Chen, S.-Y. Zhu, X. Zhou, E.D. Qin, and C.-F. Qin Induction of neutralizing antibodies against four serotypes of dengue viruses by MixBiEDIII, a tetravalent dengue vaccine PLoS ONE 9 2014 e86573
101. S. Zompi, B.H. Santich, P.R. Beatty, and E. Harris Protection from secondary dengue virus infection in a mouse model reveals the role of serotype cross-reactive B and T cells J. Immunol. 188 2012 404 416
102. R. Zust, Y.X. Toh, I. Valdes, D. Cerny, J. Heinrich, L. Hermida, E. Marcos, G. Guillen, U. Kalinke, P.Y. Shi, and K. Fink Type I interferon signals in macrophages and dendritic cells control dengue virus infection: implications for a new mouse model to test dengue vaccines J. Virol. 88 2014 7276 7285